SCHEMBL4789331

SCHEMBL4789331

CCOC(=O)c1c2c(n(-c3ccccc3)c1C)CCN(C(=O)OC(C)(C)C)C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 3/20 0.51
AR P10275 1/20 0.45
KMT2A Q03164 5/20 0.43
MEN1 O00255 4/20 0.43
ALDH1A1 P00352 2/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HIF1A Q16665 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
HDAC1 Q13547 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
PDE4D Q08499 2/20 0.42
ADORA3 P0DMS8 1/20 0.42
RECQL P46063 1/20 0.41
GAA P10253 1/20 0.41
GPR119 Q8TDV5 2/20 0.41
THRB P10828 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4786115 0.89 ADORA1 (0.47) ADORA1ALDH1A1MAPTKDM4EHDAC1
SCHEMBL12602495 0.80 ALDH1A1 (0.47) ADORA1KMT2AMEN1ALDH1A1MAPT
SCHEMBL5107551 0.77 HDAC1 (0.57) ADORA1HDAC1HDAC6GPR119
SCHEMBL31078485 0.77 HDAC1 (0.57) ADORA1HDAC1HDAC6GPR119
SCHEMBL22558480 0.74 ALDH1A1 (0.46) ADORA1KMT2AMEN1ALDH1A1MAPT
SCHEMBL18618371 0.74 ADORA1 (0.44) ADORA1KMT2AMEN1HDAC1HDAC6
SCHEMBL4788162 0.73 HDAC1 (0.56) ADORA1ARHDAC1HDAC6GAA
SCHEMBL2240101 0.72 CHRM5 (0.61) ADORA1
SCHEMBL20558294 0.72 ADORA1 (0.51) ADORA1KMT2AMEN1ALDH1A1GAA
SCHEMBL30670170 0.72 ADORA1 (0.51) ADORA1KMT2AMEN1ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008134354-A1 TNF-α PRODUCTION INHIBITOR ARRAY BIOPHARMA, INC. (US) 2008-11-06 WO disclosed